Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    PFEIFFER SYNDROME
Show Display Options
RSS Create an RSS feed from your search for:
PFEIFFER SYNDROME
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Condition: Medical Oncology
Intervention: Drug: BAY1187982
2 Recruiting A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Condition: Advanced Cholangiocarcinoma
Intervention: Drug: BGJ398
3 Active, not recruiting Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Condition: Solid Tumor
Intervention: Drug: ARQ 087
4 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib
5 Not yet recruiting Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer
Conditions: FGFR Gene Amplification;   FGFR1 Gene Amplification;   FGFR2 Gene Amplification;   FGFR2 Gene Mutation;   FGFR3 Gene Mutation;   Head and Neck Squamous Cell Carcinoma;   Human Papillomavirus Infection;   Recurrent Head and Neck Carcinoma;   Recurrent Nasopharynx Carcinoma;   Recurrent Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: pan FGFR Kinase Inhibitor BGJ398

Study has passed its completion date and status has not been verified in more than two years.